PrednisoneThe article describes the case of a 48-year-old man who developed Pneumocystis carinii pneumonia (PCP) after treatment with prednisone for dermatomyositis.Reactions Weekly
(FDA MedWatch definition) when the patient outcome is: death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent impairment or damage A 48-year-old man developed Pneumocystis carinii pneumonia (PCP) following treatment with prednisone for dermatomyositis; ...
An event is serious (FDA MedWatch definition) when the patient outcome is: death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent impairment or damage Seven elderly patients developed Pneumocystis jiroveci pneumonia (PCP) during prednisone treatment for ...
intervention to prevent permanent impairment or damage A 70-year-old woman acquired a cytomegalovirus (CMV) infection and developed Pneumocystis carinii pneumonia (PCP) during treatment with methotrexate, and prednisone [ duration of treatment prior to reaction onset not clearly stated ] for vasculitis....
The article describes cases of three patients who developed Pneumocystis carinii pneumonia (PCP) after immunosuppression with cyclophosphamide and prednisone was withdrawn. One of the patients subsequently died. Authors of the study said that the 3 cases suggest that the need for PCP prophylaxis can ...